Wallentin L - Search Results

1

Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.

James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, Wallentin L, Lagerqvist B; SCAAR Study Group. James SK, et al. Among authors: wallentin l. N Engl J Med. 2009 May 7;360(19):1933-45. doi: 10.1056/NEJMoa0809902. N Engl J Med. 2009. PMID: 19420363 Free article.

2

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study.

Stenestrand U, Wallentin L. Stenestrand U, et al. Among authors: wallentin l. Lancet. 2002 May 25;359(9320):1805-11. doi: 10.1016/S0140-6736(02)08710-X. Lancet. 2002. PMID: 12044375

3

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.

Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins LE, Nilsson T, Pehrsson K, Siegbahn A, Swahn E. Wallentin L, et al. Eur Heart J. 2003 May;24(10):897-908. doi: 10.1016/s0195-668x(03)00006-x. Eur Heart J. 2003. PMID: 12714021 Clinical Trial.

4

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.

Stenestrand U, Wallentin L; Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U, et al. Among authors: wallentin l. Arch Intern Med. 2003 Apr 28;163(8):965-71. doi: 10.1001/archinte.163.8.965. Arch Intern Med. 2003. PMID: 12719207

5

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Norhammar A, Malmberg K, Rydén L, Tornvall P, Stenestrand U, Wallentin L; Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Norhammar A, et al. Among authors: wallentin l. Eur Heart J. 2003 May;24(9):838-44. doi: 10.1016/s0195-668x(02)00828-x. Eur Heart J. 2003. PMID: 12727151

6

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.

Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B; FRISC-II Study Group. Venge P, et al. Among authors: wallentin l. Clin Chem. 2003 Jun;49(6 Pt 1):880-6. doi: 10.1373/49.6.880. Clin Chem. 2003. PMID: 12765983 Clinical Trial.

7

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.

James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. James SK, et al. Among authors: wallentin l. Circulation. 2003 Jul 22;108(3):275-81. doi: 10.1161/01.CIR.0000079170.10579.DC. Epub 2003 Jul 7. Circulation. 2003. PMID: 12847065 Clinical Trial.

8

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.

James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, Lindahl B. James S, et al. Among authors: wallentin l. Am J Med. 2003 Aug 15;115(3):178-84. doi: 10.1016/s0002-9343(03)00348-6. Am J Med. 2003. PMID: 12935823 Clinical Trial.

9

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.

Wallentin L, Wilcox RG, Weaver WD, Emanuelsson H, Goodvin A, Nyström P, Bylock A; ESTEEM Investigators. Wallentin L, et al. Lancet. 2003 Sep 6;362(9386):789-97. doi: 10.1016/S0140-6736(03)14287-0. Lancet. 2003. PMID: 13678873 Clinical Trial.

10

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease.

Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Wallentin L. Diderholm E, et al. Among authors: wallentin l. Am J Med. 2003 Dec 1;115(8):606-12. doi: 10.1016/j.amjmed.2003.06.003. Am J Med. 2003. PMID: 14656612 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

845 results

Search Page

Filters